Skip to main content
Home

Main navigation

  • Our Company
    • Who we are
    • Executive Committee
    • Board of Directors
    • Scientific Advisory Board
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
  • Investors
    • Press releases
    • Financial information
    • Stock Information
    • Shareholder information
    • Corporate governance
    • Events
    • IPO
  • Partnering
  • News & Events
    • Press releases
    • Events
    • Stay in touch
    • Interview with our CEO
  • Careers
  • Contact

User account menu

  • Log in

Press releases

Go back to Investors overview
June 21, 2022

Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca™

PDF icon
EN
PDF icon
NL
May 25, 2022

Biotalys’ First Biocontrol Evoca Wins World BioProtection Award 2022 for Best Biofungicide Product

PDF icon
EN
PDF icon
NL
May 19, 2022

Latest Field Trials Validate Strength of Biotalys’ First Biocontrol Evoca 

PDF icon
EN
PDF icon
NL
May 3, 2022

Biotalys Obtains New Fungicide Resistance Class for its First Biofungicide

PDF icon
EN
PDF icon
NL
April 29, 2022

Information on the total number of voting rights and shares

PDF icon
EN
PDF icon
NL
April 18, 2022

Biotalys Appoints Michiel van Lookeren Campagne to Board of Directors

PDF icon
EN
PDF icon
NL
April 15, 2022

Results of the Annual and Extraordinary Shareholders’ Meetings

PDF icon
EN
PDF icon
NL
March 31, 2022

Biotalys Appoints Carlo Boutton as Chief Scientific Officer

PDF icon
EN
PDF icon
NL
March 15, 2022

Invitation to the Annual and Extraordinary Shareholders’ Meetings

PDF icon
EN
PDF icon
NL
March 11, 2022

Biotalys Reports Full Year 2021 Financial Results and Business Highlights

PDF icon
EN
PDF icon
NL
February 15, 2022

Notice of Full Year 2021 Results and Business Highlights

PDF icon
EN
PDF icon
NL
January 31, 2022

Information on the total number of voting rights and shares

PDF icon
EN
PDF icon
NL
January 27, 2022

Biotalys Appoints Kwizda Agro as Formulator of Its Protein-Based Biocontrols

PDF icon
EN
PDF icon
NL
January 25, 2022

Biotalys Achieves Breakthrough in Protein Expression Increasing Commercial Potential for its first BioFungicide Evoca

PDF icon
EN
PDF icon
NL
January 12, 2022

Biotalys and Olon Enter into Long-Term Partnership for the Production of Protein-Based Biocontrols

PDF icon
EN
PDF icon
NL

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page >

Social Menu

  • Twitter
  • LinkedIn
  • Email

Subscribe to our news

Footer navigation (primary)

  • Our Company
    • Who we are
    • Executive Committee
    • Board of Directors
    • Scientific Advisory Board
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
  • Investors

Footer navigation (secondary)

  • Partnering
  • Media
    • Press releases
    • Events
    • Download section
    • Stay in touch
  • Contact
  • Careers

Home

Biotalys NV
Buchtenstraat 11
Ghent 9051, Belgium

Biotalys, Inc.
2520 Meridian Parkway, Suite 480
Durham, NC 27713,
United States

Phone: +32 (0)9 274 5400
info@biotalys.com

© Copyright 2022 Biotalys NV | Privacy Policy | General Purchasing Conditions